<!DOCTYPE html><html lang="en"><head>
  <meta charset="UTF-8"><title>AbbVie Inc. (ABBV)</title>
  <link rel="stylesheet" href="/static/css/retro.css">
  <style>.container{max-width:none;width:100%;}</style>
</head><body><div class="container">
  <h1>AbbVie Inc. — ABBV</h1>

  <div class="chart-block">
    
    <style>
        table {
            width: 80%;
            margin-left: auto;
            margin-right: auto;
            border-collapse: collapse;
            text-align: center;
            font-family: 'Arial', sans-serif;
        }
        th, td {
            padding: 8px 12px;
        }
    </style>
    <table>
    <tr><th>Close Price</th><th>Market Cap</th><th>P/E Ratio</th><th>Forward P/E Ratio</th><th>Implied Growth*</th><th>Implied Forward Growth*</th><th>Dividend</th><th>P/B Ratio</th></tr><tr><td>$213.00</td><td>$376.28B</td><td>101.4</td><td>17.6</td><td>30.2%</td><td>10.0%</td><td>$6.56</td><td>-2048.1</td></tr></table>
  </div>

  <div class="chart-block">
    <h2>Revenue &amp; Net Income</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_revenue_net_income_chart.png" alt="Revenue & Net Income">
    <div class="table-wrap"><style type="text/css">
#T_ea58e_row1_col4, #T_ea58e_row1_col5, #T_ea58e_row1_col6, #T_ea58e_row3_col4, #T_ea58e_row4_col4, #T_ea58e_row5_col4 {
  color: green;
}
#T_ea58e_row2_col4, #T_ea58e_row2_col5, #T_ea58e_row2_col6, #T_ea58e_row3_col5, #T_ea58e_row3_col6, #T_ea58e_row4_col5, #T_ea58e_row4_col6, #T_ea58e_row5_col5, #T_ea58e_row5_col6 {
  color: red;
}
</style>
<table id="T_ea58e">
  <thead>
    <tr>
      <th class="blank level0" >&nbsp;</th>
      <th id="T_ea58e_level0_col0" class="col_heading level0 col0" >Date</th>
      <th id="T_ea58e_level0_col1" class="col_heading level0 col1" >Revenue</th>
      <th id="T_ea58e_level0_col2" class="col_heading level0 col2" >Net Income</th>
      <th id="T_ea58e_level0_col3" class="col_heading level0 col3" >EPS</th>
      <th id="T_ea58e_level0_col4" class="col_heading level0 col4" >Revenue Change</th>
      <th id="T_ea58e_level0_col5" class="col_heading level0 col5" >Net Income Change</th>
      <th id="T_ea58e_level0_col6" class="col_heading level0 col6" >EPS Change</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="T_ea58e_level0_row0" class="row_heading level0 row0" >0</th>
      <td id="T_ea58e_row0_col0" class="data row0 col0" >2021-12-31</td>
      <td id="T_ea58e_row0_col1" class="data row0 col1" >$56.2B</td>
      <td id="T_ea58e_row0_col2" class="data row0 col2" >$11.5B</td>
      <td id="T_ea58e_row0_col3" class="data row0 col3" >$6.53</td>
      <td id="T_ea58e_row0_col4" class="data row0 col4" >N/A</td>
      <td id="T_ea58e_row0_col5" class="data row0 col5" >N/A</td>
      <td id="T_ea58e_row0_col6" class="data row0 col6" >N/A</td>
    </tr>
    <tr>
      <th id="T_ea58e_level0_row1" class="row_heading level0 row1" >1</th>
      <td id="T_ea58e_row1_col0" class="data row1 col0" >2022-12-31</td>
      <td id="T_ea58e_row1_col1" class="data row1 col1" >$58.1B</td>
      <td id="T_ea58e_row1_col2" class="data row1 col2" >$11.8B</td>
      <td id="T_ea58e_row1_col3" class="data row1 col3" >$6.69</td>
      <td id="T_ea58e_row1_col4" class="data row1 col4" >3.3%</td>
      <td id="T_ea58e_row1_col5" class="data row1 col5" >2.5%</td>
      <td id="T_ea58e_row1_col6" class="data row1 col6" >2.5%</td>
    </tr>
    <tr>
      <th id="T_ea58e_level0_row2" class="row_heading level0 row2" >2</th>
      <td id="T_ea58e_row2_col0" class="data row2 col0" >2023-12-31</td>
      <td id="T_ea58e_row2_col1" class="data row2 col1" >$54.3B</td>
      <td id="T_ea58e_row2_col2" class="data row2 col2" >$4.9B</td>
      <td id="T_ea58e_row2_col3" class="data row2 col3" >$2.75</td>
      <td id="T_ea58e_row2_col4" class="data row2 col4" >-6.4%</td>
      <td id="T_ea58e_row2_col5" class="data row2 col5" >-58.9%</td>
      <td id="T_ea58e_row2_col6" class="data row2 col6" >-58.8%</td>
    </tr>
    <tr>
      <th id="T_ea58e_level0_row3" class="row_heading level0 row3" >3</th>
      <td id="T_ea58e_row3_col0" class="data row3 col0" >2024-12-31</td>
      <td id="T_ea58e_row3_col1" class="data row3 col1" >$56.3B</td>
      <td id="T_ea58e_row3_col2" class="data row3 col2" >$4.3B</td>
      <td id="T_ea58e_row3_col3" class="data row3 col3" >$2.40</td>
      <td id="T_ea58e_row3_col4" class="data row3 col4" >3.7%</td>
      <td id="T_ea58e_row3_col5" class="data row3 col5" >-12.0%</td>
      <td id="T_ea58e_row3_col6" class="data row3 col6" >-12.8%</td>
    </tr>
    <tr>
      <th id="T_ea58e_level0_row4" class="row_heading level0 row4" >4</th>
      <td id="T_ea58e_row4_col0" class="data row4 col0" >TTM 2025-03-31</td>
      <td id="T_ea58e_row4_col1" class="data row4 col1" >$57.4B</td>
      <td id="T_ea58e_row4_col2" class="data row4 col2" >$4.2B</td>
      <td id="T_ea58e_row4_col3" class="data row4 col3" >$2.34</td>
      <td id="T_ea58e_row4_col4" class="data row4 col4" >1.8%</td>
      <td id="T_ea58e_row4_col5" class="data row4 col5" >-1.9%</td>
      <td id="T_ea58e_row4_col6" class="data row4 col6" >-2.5%</td>
    </tr>
    <tr>
      <th id="T_ea58e_level0_row5" class="row_heading level0 row5" >5</th>
      <td id="T_ea58e_row5_col0" class="data row5 col0" >Average</td>
      <td id="T_ea58e_row5_col1" class="data row5 col1" ></td>
      <td id="T_ea58e_row5_col2" class="data row5 col2" ></td>
      <td id="T_ea58e_row5_col3" class="data row5 col3" ></td>
      <td id="T_ea58e_row5_col4" class="data row5 col4" >0.6%</td>
      <td id="T_ea58e_row5_col5" class="data row5 col5" >-17.6%</td>
      <td id="T_ea58e_row5_col6" class="data row5 col6" >-17.9%</td>
    </tr>
  </tbody>
</table>
</div>
  </div>

  <div class="chart-block">
    <h2>EPS</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_eps_chart.png" alt="EPS">
  </div>

  <div class="chart-block">
    <h2>Forecasts</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_Revenue_Net_Income_Forecast.png" alt="Revenue/Net Income Forecast">
    <img class="chart-img chart-block" src="../charts/ABBV_EPS_Forecast.png" alt="EPS Forecast">
  </div>

  <div class="chart-block">
    <h2>Y/Y % Change</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_revenue_yoy_change.png" alt="Revenue YoY Change">
    <img class="chart-img chart-block" src="../charts/ABBV_eps_yoy_change.png" alt="EPS YoY Change">
    <div class="table-wrap">
    <html>
    <head>
    <title>YoY Growth Rates</title>
    <style>
        .table {
            width: 80%;
            margin-left: auto;
            margin-right: auto;
            border-collapse: collapse;
        }
        th, td {
            text-align: center;
            padding: 8px;
            border: 1px solid #ddd;
        }
        th {
            background-color: #f2f2f2;
        }
        body {
            font-family: Arial, sans-serif;
        }
    </style>
    </head>
    <body>
        <h2 style="text-align:center;">ABBV Year-over-Year Growth</h2>
        <style type="text/css">
#T_08e6e td.col-1 {
  text-align: center;
}
#T_08e6e td.col-1 {
  text-align: center;
}
#T_08e6e td.col-1 {
  text-align: center;
}
#T_08e6e td.col-1 {
  text-align: center;
}
#T_08e6e_row0_col1, #T_08e6e_row0_col3, #T_08e6e_row0_col4, #T_08e6e_row0_col5, #T_08e6e_row0_col6, #T_08e6e_row1_col4, #T_08e6e_row1_col5, #T_08e6e_row2_col1, #T_08e6e_row2_col4, #T_08e6e_row2_col5, #T_08e6e_row2_col6, #T_08e6e_row3_col4, #T_08e6e_row3_col5 {
  color: green;
}
#T_08e6e_row0_col2, #T_08e6e_row2_col2, #T_08e6e_row2_col3 {
  color: red;
}
</style>
<table id="T_08e6e">
  <thead>
    <tr>
      <th class="blank level0" >&nbsp;</th>
      <th id="T_08e6e_level0_col0" class="col_heading level0 col0" >2021</th>
      <th id="T_08e6e_level0_col1" class="col_heading level0 col1" >2022</th>
      <th id="T_08e6e_level0_col2" class="col_heading level0 col2" >2023</th>
      <th id="T_08e6e_level0_col3" class="col_heading level0 col3" >2024</th>
      <th id="T_08e6e_level0_col4" class="col_heading level0 col4" >2025</th>
      <th id="T_08e6e_level0_col5" class="col_heading level0 col5" >2026</th>
      <th id="T_08e6e_level0_col6" class="col_heading level0 col6" >Average</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="T_08e6e_level0_row0" class="row_heading level0 row0" >Revenue Growth (%)</th>
      <td id="T_08e6e_row0_col0" class="data row0 col0" ></td>
      <td id="T_08e6e_row0_col1" class="data row0 col1" >3.3%</td>
      <td id="T_08e6e_row0_col2" class="data row0 col2" >-6.4%</td>
      <td id="T_08e6e_row0_col3" class="data row0 col3" >3.7%</td>
      <td id="T_08e6e_row0_col4" class="data row0 col4" >7.5%</td>
      <td id="T_08e6e_row0_col5" class="data row0 col5" >9.1%</td>
      <td id="T_08e6e_row0_col6" class="data row0 col6" >3.4%</td>
    </tr>
    <tr>
      <th id="T_08e6e_level0_row1" class="row_heading level0 row1" >Revenue Analysts (#)</th>
      <td id="T_08e6e_row1_col0" class="data row1 col0" >0</td>
      <td id="T_08e6e_row1_col1" class="data row1 col1" >0</td>
      <td id="T_08e6e_row1_col2" class="data row1 col2" >0</td>
      <td id="T_08e6e_row1_col3" class="data row1 col3" >0</td>
      <td id="T_08e6e_row1_col4" class="data row1 col4" >8</td>
      <td id="T_08e6e_row1_col5" class="data row1 col5" >8</td>
      <td id="T_08e6e_row1_col6" class="data row1 col6" ></td>
    </tr>
    <tr>
      <th id="T_08e6e_level0_row2" class="row_heading level0 row2" >EPS Growth (%)</th>
      <td id="T_08e6e_row2_col0" class="data row2 col0" ></td>
      <td id="T_08e6e_row2_col1" class="data row2 col1" >2.5%</td>
      <td id="T_08e6e_row2_col2" class="data row2 col2" >-58.9%</td>
      <td id="T_08e6e_row2_col3" class="data row2 col3" >-12.0%</td>
      <td id="T_08e6e_row2_col4" class="data row2 col4" >396.8%</td>
      <td id="T_08e6e_row2_col5" class="data row2 col5" >19.2%</td>
      <td id="T_08e6e_row2_col6" class="data row2 col6" >69.5%</td>
    </tr>
    <tr>
      <th id="T_08e6e_level0_row3" class="row_heading level0 row3" >EPS Analysts (#)</th>
      <td id="T_08e6e_row3_col0" class="data row3 col0" >0</td>
      <td id="T_08e6e_row3_col1" class="data row3 col1" >0</td>
      <td id="T_08e6e_row3_col2" class="data row3 col2" >0</td>
      <td id="T_08e6e_row3_col3" class="data row3 col3" >0</td>
      <td id="T_08e6e_row3_col4" class="data row3 col4" >8</td>
      <td id="T_08e6e_row3_col5" class="data row3 col5" >8</td>
      <td id="T_08e6e_row3_col6" class="data row3 col6" ></td>
    </tr>
  </tbody>
</table>

    </body>
    </html>
    </div>
  </div>

  <div class="chart-block">
    <h2>Expenses</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_rev_expense_chart.png" alt="Revenue vs Expenses">
    <img class="chart-img chart-block" src="../charts/ABBV_expense_percent_chart.png" alt="Expenses % of Revenue">
    <div class="table-wrap"><table class="dataframe">
  <thead>
    <tr style="text-align: center;">
      <th>Year</th>
      <th>Revenue ($)</th>
      <th>Cost of Revenue ($)</th>
      <th>R&amp;D ($)</th>
      <th>SG&amp;A ($)</th>
      <th>Facilities / D&amp;A ($)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>2021</td>
      <td>$56.2B</td>
      <td>$8.9B</td>
      <td>$8.0B</td>
      <td>$12.3B</td>
      <td>$8.5B</td>
    </tr>
    <tr>
      <td>2022</td>
      <td>$58.1B</td>
      <td>$8.9B</td>
      <td>$6.5B</td>
      <td>$15.3B</td>
      <td>$8.5B</td>
    </tr>
    <tr>
      <td>2023</td>
      <td>$54.3B</td>
      <td>$11.7B</td>
      <td>$7.7B</td>
      <td>$12.9B</td>
      <td>$8.7B</td>
    </tr>
    <tr>
      <td>2024</td>
      <td>$56.3B</td>
      <td>$8.5B</td>
      <td>$12.8B</td>
      <td>$14.8B</td>
      <td>$8.4B</td>
    </tr>
    <tr>
      <td>TTM</td>
      <td>$58.3B</td>
      <td>$8.7B</td>
      <td>$13.1B</td>
      <td>$14.6B</td>
      <td>$8.3B</td>
    </tr>
  </tbody>
</table></div>
    <div class="table-wrap"><table class="dataframe">
  <thead>
    <tr style="text-align: center;">
      <th>Year</th>
      <th>Revenue Change (%)</th>
      <th>Cost of Revenue Change (%)</th>
      <th>R&amp;D Change (%)</th>
      <th>SG&amp;A Change (%)</th>
      <th>Facilities / D&amp;A Change (%)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>2022</td>
      <td>3.30</td>
      <td>0.25</td>
      <td>-19.09</td>
      <td>23.57</td>
      <td>-0.63</td>
    </tr>
    <tr>
      <td>2023</td>
      <td>-6.44</td>
      <td>30.96</td>
      <td>17.90</td>
      <td>-15.65</td>
      <td>2.73</td>
    </tr>
    <tr>
      <td>2024</td>
      <td>3.71</td>
      <td>-27.30</td>
      <td>66.66</td>
      <td>14.61</td>
      <td>-3.59</td>
    </tr>
    <tr>
      <td>TTM</td>
      <td>3.54</td>
      <td>1.97</td>
      <td>2.43</td>
      <td>-0.99</td>
      <td>-1.38</td>
    </tr>
  </tbody>
</table></div>
    <div class="table-wrap">No unmapped expenses.</div>
  </div>

  
  <div class="chart-block">
    <h2>Segment Performance (Axis 1)</h2>
    <div class="carousel-container chart-block">
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis1_ABBV_Aesthetics_Member.png" alt="axis1_ABBV_Aesthetics_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis1_ABBV_Eye_Care_Member.png" alt="axis1_ABBV_Eye_Care_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis1_ABBV_Hematologic_Oncology_Member.png" alt="axis1_ABBV_Hematologic_Oncology_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis1_ABBV_Immunology_Member.png" alt="axis1_ABBV_Immunology_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis1_ABBV_Neuroscience_Member.png" alt="axis1_ABBV_Neuroscience_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis1_ABBV_Other_Key_Products_Member.png" alt="axis1_ABBV_Other_Key_Products_Member.png"></div>
</div>
    <div class="segment-table-wrapper">
      <div class="table-wrap">
        <style>
.table-wrap{overflow:auto; max-width:100%;}
.segment-pivot { width:100%; border-collapse:collapse; font-family: Arial, sans-serif; font-size:14px; }
.segment-pivot thead th { position:sticky; top:0; background:#fff; z-index:1; border-bottom:1px solid #ddd; }
.segment-pivot th, .segment-pivot td { padding:6px 8px; border-bottom:1px solid #f0f0f0; }
.segment-pivot tbody tr:nth-child(even){ background:#fafafa; }
.segment-pivot td, .segment-pivot th { white-space:nowrap; }
.segment-pivot td { font-variant-numeric: tabular-nums; text-align:right; }
.segment-pivot td:first-child, .segment-pivot th:first-child { text-align:left; }
.table-note { font-size:12px; color:#666; margin:6px 0 8px; }
</style>
<div class="table-note">SEGMENTS v2025-09-09 · 2025-09-04 20:28 UTC — Values are shown in a single scale for this table: <b>$B</b>. TTM values are <b>bold</b>. “% of Total (TTM)” shows revenue mix.</div>
<div class='table-wrap'><table class="dataframe segment-pivot">
  <thead>
    <tr style="text-align: right;">
      <th>Segment</th>
      <th>2022 Rev ($B)</th>
      <th>2022 OI ($B)</th>
      <th>2023 Rev ($B)</th>
      <th>2023 OI ($B)</th>
      <th>2024 Rev ($B)</th>
      <th>2024 OI ($B)</th>
      <th>TTM Rev ($B)</th>
      <th>TTM OI ($B)</th>
      <th>% of Total (TTM)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Immunology Member</td>
      <td>57.8B</td>
      <td>0.00B</td>
      <td>52.3B</td>
      <td>0.00B</td>
      <td>53.4B</td>
      <td>0.00B</td>
      <td><strong>53.4B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>51.2%</td>
    </tr>
    <tr>
      <td>Neuroscience Member</td>
      <td>13.1B</td>
      <td>0.00B</td>
      <td>15.4B</td>
      <td>0.00B</td>
      <td>18.0B</td>
      <td>0.00B</td>
      <td><strong>18.0B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>17.3%</td>
    </tr>
    <tr>
      <td>Hematologic Oncology Member</td>
      <td>12.0B</td>
      <td>0.00B</td>
      <td>10.9B</td>
      <td>0.00B</td>
      <td>12.1B</td>
      <td>0.00B</td>
      <td><strong>12.1B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>11.6%</td>
    </tr>
    <tr>
      <td>Aesthetics Member</td>
      <td>10.7B</td>
      <td>0.00B</td>
      <td>10.6B</td>
      <td>0.00B</td>
      <td>10.4B</td>
      <td>0.00B</td>
      <td><strong>10.4B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>9.9%</td>
    </tr>
    <tr>
      <td>Other Key Products Member</td>
      <td>6.43B</td>
      <td>0.00B</td>
      <td>6.34B</td>
      <td>0.00B</td>
      <td>5.91B</td>
      <td>0.00B</td>
      <td><strong>5.91B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>5.7%</td>
    </tr>
    <tr>
      <td>Eye Care Member</td>
      <td>5.40B</td>
      <td>0.00B</td>
      <td>4.83B</td>
      <td>0.00B</td>
      <td>4.48B</td>
      <td>0.00B</td>
      <td><strong>4.48B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>4.3%</td>
    </tr>
  </tbody>
</table></div>
      </div>
    </div>
  </div>
  
  
  <div class="chart-block">
    <h2>Segment Performance (Axis 2)</h2>
    <div class="carousel-container chart-block">
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Alphagan_Combigan_Member.png" alt="axis2_ABBV_Alphagan_Combigan_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Botox_Cosmetic_Member.png" alt="axis2_ABBV_Botox_Cosmetic_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Botox_Therapeutic_Member.png" alt="axis2_ABBV_Botox_Therapeutic_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Creon_Member.png" alt="axis2_ABBV_Creon_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Duodopa_Member.png" alt="axis2_ABBV_Duodopa_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Elahere_Member.png" alt="axis2_ABBV_Elahere_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Epkinly_Member.png" alt="axis2_ABBV_Epkinly_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_H_U_M_I_R_A_Member.png" alt="axis2_ABBV_H_U_M_I_R_A_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Imbruvica_Member.png" alt="axis2_ABBV_Imbruvica_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Juvederm_Collection_Member.png" alt="axis2_ABBV_Juvederm_Collection_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Linzess_Constella_Member.png" alt="axis2_ABBV_Linzess_Constella_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Lumigan_Ganfort_Member.png" alt="axis2_ABBV_Lumigan_Ganfort_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_M_A_V_Y_R_E_T_Member.png" alt="axis2_ABBV_M_A_V_Y_R_E_T_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Other_Aesthetics_Member.png" alt="axis2_ABBV_Other_Aesthetics_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Other_Eye_Care_Member.png" alt="axis2_ABBV_Other_Eye_Care_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Other_Neuroscience_Member.png" alt="axis2_ABBV_Other_Neuroscience_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Other_Oncology_Member.png" alt="axis2_ABBV_Other_Oncology_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Other_Products_Member.png" alt="axis2_ABBV_Other_Products_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Ozurdex_Member.png" alt="axis2_ABBV_Ozurdex_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Qulipta_Member.png" alt="axis2_ABBV_Qulipta_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_R_I_N_V_O_Q_Member.png" alt="axis2_ABBV_R_I_N_V_O_Q_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_S_K_Y_R_I_Z_I_Member.png" alt="axis2_ABBV_S_K_Y_R_I_Z_I_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Ubrelvy_Member.png" alt="axis2_ABBV_Ubrelvy_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_V_E_N_C_L_E_X_T_A_Member.png" alt="axis2_ABBV_V_E_N_C_L_E_X_T_A_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Vraylar_Member.png" alt="axis2_ABBV_Vraylar_Member.png"></div>
<div class="carousel-item"><img class="chart-img" src="../charts/ABBV/axis2_ABBV_Vyalev_Member.png" alt="axis2_ABBV_Vyalev_Member.png"></div>
</div>
    <div class="segment-table-wrapper">
      <div class="table-wrap">
        <style>
.table-wrap{overflow:auto; max-width:100%;}
.segment-pivot { width:100%; border-collapse:collapse; font-family: Arial, sans-serif; font-size:14px; }
.segment-pivot thead th { position:sticky; top:0; background:#fff; z-index:1; border-bottom:1px solid #ddd; }
.segment-pivot th, .segment-pivot td { padding:6px 8px; border-bottom:1px solid #f0f0f0; }
.segment-pivot tbody tr:nth-child(even){ background:#fafafa; }
.segment-pivot td, .segment-pivot th { white-space:nowrap; }
.segment-pivot td { font-variant-numeric: tabular-nums; text-align:right; }
.segment-pivot td:first-child, .segment-pivot th:first-child { text-align:left; }
.table-note { font-size:12px; color:#666; margin:6px 0 8px; }
</style>
<div class="table-note">SEGMENTS v2025-09-09 · 2025-09-04 20:28 UTC — Values are shown in a single scale for this table: <b>$B</b>. TTM values are <b>bold</b>. “% of Total (TTM)” shows revenue mix.</div>
<div class='table-wrap'><table class="dataframe segment-pivot">
  <thead>
    <tr style="text-align: right;">
      <th>Segment</th>
      <th>2022 Rev ($B)</th>
      <th>2022 OI ($B)</th>
      <th>2023 Rev ($B)</th>
      <th>2023 OI ($B)</th>
      <th>2024 Rev ($B)</th>
      <th>2024 OI ($B)</th>
      <th>TTM Rev ($B)</th>
      <th>TTM OI ($B)</th>
      <th>% of Total (TTM)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>S K Y R I Z I Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>9.62B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>238.9%</td>
    </tr>
    <tr>
      <td>R I N V O Q Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>3.64B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>90.5%</td>
    </tr>
    <tr>
      <td>Other Products Member</td>
      <td>4.14B</td>
      <td>0.00B</td>
      <td>3.04B</td>
      <td>0.00B</td>
      <td>3.03B</td>
      <td>0.00B</td>
      <td><strong>2.62B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>65.1%</td>
    </tr>
    <tr>
      <td>Qulipta Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.95B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>23.6%</td>
    </tr>
    <tr>
      <td>Botox Therapeutic Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.69B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>17.2%</td>
    </tr>
    <tr>
      <td>Vraylar Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.65B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>16.0%</td>
    </tr>
    <tr>
      <td>Ubrelvy Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.50B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>12.5%</td>
    </tr>
    <tr>
      <td>Vyalev Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.43B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>10.6%</td>
    </tr>
    <tr>
      <td>Elahere Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.35B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>8.8%</td>
    </tr>
    <tr>
      <td>V E N C L E X T A Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.32B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>7.9%</td>
    </tr>
    <tr>
      <td>Creon Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.13B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>3.3%</td>
    </tr>
    <tr>
      <td>Epkinly Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.13B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>3.2%</td>
    </tr>
    <tr>
      <td>Lumigan Ganfort Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.03B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.7%</td>
    </tr>
    <tr>
      <td>Other Aesthetics Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.03B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.7%</td>
    </tr>
    <tr>
      <td>Other Oncology Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>0.00B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>0.1%</td>
    </tr>
    <tr>
      <td>Ozurdex Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.01B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-0.3%</td>
    </tr>
    <tr>
      <td>Other Neuroscience Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.04B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-1.0%</td>
    </tr>
    <tr>
      <td>Alphagan Combigan Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.05B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-1.2%</td>
    </tr>
    <tr>
      <td>M A V Y R E T Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.06B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-1.5%</td>
    </tr>
    <tr>
      <td>Linzess Constella Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.09B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-2.2%</td>
    </tr>
    <tr>
      <td>Duodopa Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.10B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-2.5%</td>
    </tr>
    <tr>
      <td>Other Eye Care Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.11B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-2.7%</td>
    </tr>
    <tr>
      <td>Botox Cosmetic Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.30B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-7.5%</td>
    </tr>
    <tr>
      <td>Imbruvica Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.44B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-11.0%</td>
    </tr>
    <tr>
      <td>Juvederm Collection Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-0.46B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-11.5%</td>
    </tr>
    <tr>
      <td>H U M I R A Member</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td>–</td>
      <td><strong>-14.4B</strong></td>
      <td><strong>0.00B</strong></td>
      <td>-357.7%</td>
    </tr>
  </tbody>
</table></div>
      </div>
    </div>
  </div>
  

  <div class="chart-block">
    <h2>Balance Sheet</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_balance_sheet_chart.png" alt="Balance Sheet">
    <div class="table-wrap"><style type="text/css">
#T_c3d84_row5_col1 {
  color: red;
}
</style>
<table id="T_c3d84">
  <thead>
    <tr>
      <th class="blank level0" >&nbsp;</th>
      <th id="T_c3d84_level0_col0" class="col_heading level0 col0" >Metric</th>
      <th id="T_c3d84_level0_col1" class="col_heading level0 col1" >Value</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="T_c3d84_level0_row0" class="row_heading level0 row0" >0</th>
      <td id="T_c3d84_row0_col0" class="data row0 col0" >Total Assets</td>
      <td id="T_c3d84_row0_col1" class="data row0 col1" >$136,165M</td>
    </tr>
    <tr>
      <th id="T_c3d84_level0_row1" class="row_heading level0 row1" >1</th>
      <td id="T_c3d84_row1_col0" class="data row1 col0" >Cash</td>
      <td id="T_c3d84_row1_col1" class="data row1 col1" >$5,175M</td>
    </tr>
    <tr>
      <th id="T_c3d84_level0_row2" class="row_heading level0 row2" >2</th>
      <td id="T_c3d84_row2_col0" class="data row2 col0" >Total Liabilities</td>
      <td id="T_c3d84_row2_col1" class="data row2 col1" >$134,703M</td>
    </tr>
    <tr>
      <th id="T_c3d84_level0_row3" class="row_heading level0 row3" >3</th>
      <td id="T_c3d84_row3_col0" class="data row3 col0" >Total Debt</td>
      <td id="T_c3d84_row3_col1" class="data row3 col1" >$69,889M</td>
    </tr>
    <tr>
      <th id="T_c3d84_level0_row4" class="row_heading level0 row4" >4</th>
      <td id="T_c3d84_row4_col0" class="data row4 col0" >Total Equity</td>
      <td id="T_c3d84_row4_col1" class="data row4 col1" >$1,420M</td>
    </tr>
    <tr>
      <th id="T_c3d84_level0_row5" class="row_heading level0 row5" >5</th>
      <td id="T_c3d84_row5_col0" class="data row5 col0" >Debt to Equity Ratio</td>
      <td id="T_c3d84_row5_col1" class="data row5 col1" >49.22</td>
    </tr>
  </tbody>
</table>
</div>
  </div>

  <div class="chart-block">
    <h2>EPS &amp; Dividend</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_eps_dividend_forecast.png" alt="EPS & Dividend">
  </div>

  <div class="chart-block">
    <h2>Valuation</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_valuation_chart.png" alt="Valuation">
    <div class="table-wrap"><table border="1" class="dataframe table table-striped">
  <thead>
    <tr style="text-align: left;">
      <th>Share Price</th>
      <th>Treasury Yield</th>
      <th>Estimates</th>
      <th>Fair Value (P/E)</th>
      <th>Fair Value (P/S)</th>
      <th>Current P/S</th>
      <th>Current P/E</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>$185.30</td>
      <td>4.4%</td>
      <td>Nicks&nbsp;Growth:&nbsp;N/A<br>Nick's&nbsp;Expected&nbsp;Margin:&nbsp;N/A<br>FINVIZ&nbsp;Growth:&nbsp;15%</td>
      <td>Nicks:&nbsp;6<br>Finviz:&nbsp;28</td>
      <td>Nick's: 0.000</td>
      <td>5.7</td>
      <td>79.5</td>
    </tr>
  </tbody>
</table></div>
    <div class="table-wrap"><table border="1" class="dataframe table table-striped">
  <thead>
    <tr style="text-align: left;">
      <th>Basis</th>
      <th>Year</th>
      <th>Nicks Valuation</th>
      <th>Nicks vs Share Price</th>
      <th>Finviz Valuation</th>
      <th>Finviz vs Share Price</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>$2.34 EPS</td>
      <td>TTM</td>
      <td>$14.96</td>
      <td><span style="color: red">-91.9%</span></td>
      <td>$65.52</td>
      <td><span style="color: red">-64.6%</span></td>
    </tr>
    <tr>
      <td>$12.28 EPS</td>
      <td>2025</td>
      <td>$78.51</td>
      <td><span style="color: red">-57.6%</span></td>
      <td>$343.84</td>
      <td><span style="color: green">85.6%</span></td>
    </tr>
    <tr>
      <td>$14.06 EPS</td>
      <td>2026</td>
      <td>$89.89</td>
      <td><span style="color: red">-51.5%</span></td>
      <td>$393.68</td>
      <td><span style="color: green">112.5%</span></td>
    </tr>
  </tbody>
</table></div>
  </div>

  <div class="chart-block">
    <h2>Implied Growth</h2>
    <img class="chart-img chart-block" src="../charts/ABBV_implied_growth_plot.png" alt="Implied Growth">
    <div class="table-wrap"><table border="1" class="dataframe table table-striped implied-growth-table">
  <thead>
    <tr>
      <th></th>
      <th colspan="2" halign="left">Average</th>
      <th colspan="2" halign="left">Median</th>
      <th colspan="2" halign="left">Std Dev</th>
      <th colspan="2" halign="left">Current</th>
      <th colspan="2" halign="left">Percentile</th>
    </tr>
    <tr>
      <th></th>
      <th>TTM</th>
      <th>Forward</th>
      <th>TTM</th>
      <th>Forward</th>
      <th>TTM</th>
      <th>Forward</th>
      <th>TTM</th>
      <th>Forward</th>
      <th>TTM</th>
      <th>Forward</th>
    </tr>
    <tr>
      <th>Timeframe</th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>1 Year</th>
      <td>28.65%</td>
      <td>9.23%</td>
      <td>28.04%</td>
      <td>9.15%</td>
      <td>1.12%</td>
      <td>0.42%</td>
      <td>30.21%</td>
      <td>9.95%</td>
      <td>96.5%</td>
      <td>96.5%</td>
    </tr>
    <tr>
      <th>3 Years</th>
      <td>28.65%</td>
      <td>9.23%</td>
      <td>28.04%</td>
      <td>9.15%</td>
      <td>1.12%</td>
      <td>0.42%</td>
      <td>30.21%</td>
      <td>9.95%</td>
      <td>96.5%</td>
      <td>96.5%</td>
    </tr>
    <tr>
      <th>5 Years</th>
      <td>28.65%</td>
      <td>9.23%</td>
      <td>28.04%</td>
      <td>9.15%</td>
      <td>1.12%</td>
      <td>0.42%</td>
      <td>30.21%</td>
      <td>9.95%</td>
      <td>96.5%</td>
      <td>96.5%</td>
    </tr>
    <tr>
      <th>10 Years</th>
      <td>28.65%</td>
      <td>9.23%</td>
      <td>28.04%</td>
      <td>9.15%</td>
      <td>1.12%</td>
      <td>0.42%</td>
      <td>30.21%</td>
      <td>9.95%</td>
      <td>96.5%</td>
      <td>96.5%</td>
    </tr>
  </tbody>
</table></div>
  </div>

  <p class="chart-block"><a href="../index.html">← Back</a></p>
</div></body></html>